Download PDF
CC BY 4.0 · Indian J Med Paediatr Oncol 2024; 45(05): 443-450
DOI: 10.1055/s-0043-1766129
Case Report with Review of Literature

Pregnancy and Acute Lymphoblastic Leukemia: A Case Series and Review of Literature

Sukrita Bhattacharjee 
1   Institute of Haematology and Transfusion Medicine, Medical College Kolkata, West Bengal, India
,
Shouriyo Ghosh 
2   L/BMT Program, Vancouver General Hospital, Vancouver, Canada
,
Siddhartha Sankar Ray
1   Institute of Haematology and Transfusion Medicine, Medical College Kolkata, West Bengal, India
,
Sambit Samanta
1   Institute of Haematology and Transfusion Medicine, Medical College Kolkata, West Bengal, India
,
Nilanjan Sinha
1   Institute of Haematology and Transfusion Medicine, Medical College Kolkata, West Bengal, India
,
Sandeep Saha
3   Department of Clinical Haematology, NRS Medical College, Kolkata, West Bengal, India
,
Maitreyee Bhattacharyya 
1   Institute of Haematology and Transfusion Medicine, Medical College Kolkata, West Bengal, India
› Author Affiliations Funding None declared.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Acute lymphoblastic leukemia (ALL) diagnosed during pregnancy is rare and causes ethical and therapeutic challenges. We performed a retrospective search of ALL patients (n = 202) treated at our institution from 2015 to 2020 and found five patients diagnosed during pregnancy. In this report, we discuss the individual patients in detail and the challenges faced during their treatment. The use of established lymphoblastic leukemia treatment protocols and the modifications made therein to prevent untoward chemotherapy-related toxicities to the fetus are discussed in this study. We report the second use of rasburicase during pregnancy in literature with favorable maternal and fetal outcomes. We also present an extensive literature review of 41 cases of ALL in pregnancy previously reported. It is important to note that there is a dearth of guidelines for the treatment of these complex situations, and although certain general principles can be established, an individualized approach is needed in most cases of leukemia diagnosed during pregnancy.

Keywords

acute leukemia - ethical considerations - pregnancy - maternal well-being - fetal outcome - chemotherapy

Authors' Contributions

S.B. was involved in conceptualization, data collection, and manuscript drafting. S.G. helped in conceptualization, clinical data curation, and manuscript editing and analysis. S.S.R., S. Samanta, N.S. and S. Saha were involved in Institutional Medical Boards convened for patient management strategies. M.B. was involved in conceptualization, manuscript editing, analysis, and overall supervision.


Ethics Approval

Retrospective study


Consent for Publication

Yes.


Availability of Data and Material

Available for publication/review.




Publication History

Article published online:
17 May 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Acute leukemia in pregnancy with ovarian metastasis: a case report and review of the literature - PubMed [Internet]. [cited 2020 Sep 8]. Accessed February 21, 2023 at: https://pubmed.ncbi.nlm.nih.gov/14675333/
  • 2 Saleh AJM, Alhejazi A, Ahmed SO. et al. Leukemia during pregnancy: long term follow up of 32 cases from a single institution. Hematol Oncol Stem Cell Ther 2014; 7 (02) 63-68
    CrossrefPubMedGoogle Scholar
  • 3 Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5 (05) 283-291
    CrossrefPubMedGoogle Scholar
  • 4 Ticku J, Oberoi S, Friend S, Busowski J, Langenstroer M, Baidas S. Acute lymphoblastic leukemia in pregnancy: a case report with literature review. Ther Adv Hematol 2013; 4 (05) 313-319
    CrossrefPubMedGoogle Scholar
  • 5 Ali R, Ozkalemkaş F, Ozçelik T. et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Res 2003; 27 (05) 381-385
    CrossrefPubMedGoogle Scholar
  • 6 Chelghoum Y, Vey N, Raffoux E. et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 2005; 104 (01) 110-117
    CrossrefPubMedGoogle Scholar
  • 7 Molkenboer JFM, Vos AH, Schouten HC, Vos MC. Acute lymphoblastic leukaemia in pregnancy. Neth J Med 2005; 63 (09) 361-363
    PubMedGoogle Scholar
  • 8 Dilek I, Topcu N, Demir C. et al. Hematological malignancy and pregnancy: a single-institution experience of 21 cases. Clin Lab Haematol 2006; 28 (03) 170-176
    CrossrefPubMedGoogle Scholar
  • 9 Matsouka C, Marinopoulos S, Barbaroussi D, Antsaklis A. Acute lymphoblastic leukemia during gestation. Med Oncol 2008; 25 (02) 190-193
    CrossrefPubMedGoogle Scholar
  • 10 Nakajima Y, Hattori Y, Ito S. et al. Acute leukemia during pregnancy: an investigative survey of the past 11 years. Int J Lab Hematol 2015; 37 (02) 174-180
    CrossrefPubMedGoogle Scholar
  • 11 Farhadfar N, Cerquozzi S, Hessenauer MR. et al. Acute leukemia in pregnancy: a single institution experience with 23 patients. Leuk Lymphoma 2017; 58 (05) 1052-1060
    CrossrefPubMedGoogle Scholar
  • 12 Vlijm-Kievit A, Jorna NGE, Moll E. et al. Acute lymphoblastic leukemia during the third trimester of pregnancy. Leuk Lymphoma 2018; 59 (05) 1274-1276
    CrossrefPubMedGoogle Scholar
  • 13 Santiago-López CJ, Cuan-Baltazar Y, Pérez-Partida AM, Muñoz-Pérez MJ, Soto-Vega E. Leukemia during pregnancy. Obstet Gynecol Int J 2017; 6 (06) 00225
    Google Scholar
  • 14 Kauss MA, Reiterer G, Bunaciu RP, Yen A. Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation. Exp Cell Res 2008; 314 (16) 2999-3006 https://pubmed.ncbi.nlm.nih.gov/18692045/ cited 2020Oct23 [Internet]
    CrossrefPubMedGoogle Scholar
  • 15 Milojkovic D, Apperley JF. How I treat leukemia during pregnancy. Blood 2014; 123 (07) 974-984
    CrossrefPubMedGoogle Scholar
  • 16 Brenner B, Avivi I, Lishner M. Haematological cancers in pregnancy. Vol. 379, The Lancet. Lancet Publishing Group; 2012: 580-7
    Google Scholar
  • 17 Yarbro CH, Wujcik D, Gobel BH. Cancer Nursing. Jones & Bartlett Learning; 2016. Available at: https://books.google.co.in/books?id=mGt7jgEACAAJ
    Google Scholar
  • 18 Zaidi A, Johnson L-M, Church CL. et al. Management of concurrent pregnancy and acute lymphoblastic malignancy in teenaged patients: two illustrative cases and review of the literature. J Adolesc Young Adult Oncol 2014; 3 (04) 160-175
    CrossrefPubMedGoogle Scholar
  • 19 Rousselot P, Coudé MM, Gokbuget N. et al; European Working Group on Adult ALL (EWALL) group. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL. Blood 2016; 128 (06) 774-782
    CrossrefPubMedGoogle Scholar
  • 20 Gökbuget N. Treatment of older patients with acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2016; 2016 (01) 573-579
    CrossrefPubMedGoogle Scholar
  • 21 Pye SM, Cortes J, Ault P. et al. The effects of imatinib on pregnancy outcome. Blood 2008; 111 (12) 5505-5508
    CrossrefPubMedGoogle Scholar
  • 22 Mukhopadhyay A, Dasgupta S, Kanti Ray U, Gharami F, Bose CK, Mukhopadhyay S. Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy. Ir J Med Sci 2015; 184 (01) 183-188
    CrossrefPubMedGoogle Scholar
  • 23 Cole S, Kantarjian H, Ault P, Cortés JE. Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature. Clin Lymphoma Myeloma 2009; 9 (04) 324-327
    CrossrefPubMedGoogle Scholar
  • 24 Conchon M, Sanabani SS, Serpa M. et al. Successful pregnancy and delivery in a patient with chronic myeloid leukemia while on dasatinib therapy. Adv Hematol 2010; 2010: 136252-136252
    CrossrefPubMedGoogle Scholar
  • 25 Conchon M, Sanabani SS, Bendit I, Santos FM, Serpa M, Dorliac-Llacer PE. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study. J Hematol Oncol 2009; 2 (01) 42
    CrossrefPubMedGoogle Scholar
  • 26 Stary J, Zimmermann M, Campbell M. et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. J Clin Oncol 2014; 32 (03) 174-184
    CrossrefPubMedGoogle Scholar
  • 27 Rowe JM, Buck G, Burnett AK. et al; ECOG, MRC/NCRI Adult Leukemia Working Party. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005; 106 (12) 3760-3767
    CrossrefPubMedGoogle Scholar
  • 28 Gilis L, Lebras L, Bouafia-Sauvy F. et al. Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm. Leuk Lymphoma 2012; 53 (08) 1633-1637
    CrossrefPubMedGoogle Scholar
  • 29 Chabner BA, Longo DL. Cancer Chemotherapy and Biotherapy: Principles and Practice. Wolters Kluwer Health; 2011. Available at: https://books.google.co.in/books?id=0U4aj4GZWCIC
    Google Scholar
  • 30 Fernández Fernández C, Pérez Prieto B, Argüelles Álvarez S, García González C, González García C. Leucemia aguda mieloblástica en gestante de 28 semanas. [Acute myeloblastic leukemia in a 28-week pregnant woman] Clin Invest Ginecol Obstet 2008; 35 (05) 184-186
    Google Scholar
  • 31 Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev 2008; 22 (05) 247-259
    CrossrefPubMedGoogle Scholar
  • 32 Middeke JM, Bruck N, Parmentier S, Bornhäuser M, Schetelig J. Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome. Ann Hematol 2014; 93 (03) 531-532
    CrossrefPubMedGoogle Scholar
  • 33 Howard SC, Jones DP, Pui C-H. The tumor lysis syndrome. N Engl J Med 2011; 364 (19) 1844-1854
    CrossrefPubMedGoogle Scholar
  • 34 Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Lippincott Williams & Wilkins; 2011. Available at: https://books.google.co.id/books?id=OIgTE4aynrMC
    Google Scholar
  • 35 Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003; 102 (13) 4306-4311
    CrossrefPubMedGoogle Scholar
  • 36 Provan D, Stasi R, Newland AC. et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115 (02) 168-186
    CrossrefPubMedGoogle Scholar